- Investor's Business Daily•3 days ago
Pfizer and Tesaro could follow AstraZeneca which, early Friday, unveiled strong results from a trial of Lynparza in breast cancer.
- TheStreet.com•3 days ago
AstraZeneca shares, meanwhile, were less-than-moved by the news.
- Financial Times•3 days ago
Satellite operator Inmarsat was a faller on Friday amid worries that its dividend could be jeopardised by sluggish growth at its shipping business. UBS downgraded Inmarsat to "sell", which sent ...
AZN.L : Summary for ASTRAZENECA PLC ORD SHS $0.25 - Yahoo Finance
AstraZeneca PLC (AZN.L)
LSE - LSE Delayed Price. Currency in GBp
Add to watchlist
|Bid||4,540.00 x 6100|
|Ask||4,630.00 x 13000|
|Day's Range||4,542.00 - 4,645.38|
|52 Week Range||3,680.00 - 5,505.00|
|PE Ratio (TTM)||16.56|
|Dividend & Yield||2.80 (4.97%)|
|1y Target Est||N/A|